Sonia de Assis Selected Research

Estrogens (Estrogen)

1/2017	Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
3/2013	Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.
4/2012	Pregnancy hormonal environment and mother's breast cancer risk.
6/2010	Changes in mammary caveolin-1 signaling pathways are associated with breast cancer risk in rats exposed to estradiol in utero or during prepuberty.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sonia de Assis Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 02/2023 - 12/2002
14	Neoplasms (Cancer) 02/2023 - 10/2006
7	Carcinogenesis 01/2018 - 04/2006
2	Birth Weight (Birth Weights) 01/2018 - 10/2006
2	Body Weight (Weight, Body) 01/2016 - 04/2009
2	Gestational Weight Gain 04/2009 - 04/2006
2	Weight Gain 04/2009 - 04/2006
1	Glucose Intolerance 01/2024
1	Chronic Disease (Chronic Diseases) 01/2024
1	Hypoxia (Hypoxemia) 01/2016
1	Overweight 01/2016
1	Spontaneous Abortion (Miscarriage) 03/2013
1	Obesity 04/2006

Drug/Important Bio-Agent (IBA)

8	CarcinogensIBA 01/2021 - 04/2006
6	anthraceneIBA 01/2018 - 04/2006
5	Estradiol (Delestrogen)FDA LinkGeneric 11/2013 - 10/2006
4	Estrogens (Estrogen)FDA Link 01/2017 - 06/2010
4	LeptinIBA 11/2013 - 04/2006
3	Proteins (Proteins, Gene)FDA Link 02/2023 - 09/2011
3	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
3	lardIBA 01/2016 - 06/2014
3	Hormones (Hormone)IBA 03/2013 - 04/2009
2	DDTIBA 01/2024 - 02/2023
2	PesticidesIBA 01/2024 - 02/2023
2	RNA (Ribonucleic Acid)IBA 02/2023 - 07/2017
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 07/2017 - 01/2016
2	Estrogen ReceptorsIBA 01/2017 - 09/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 09/2015
2	9,10-Dimethyl-1,2-benzanthraceneIBA 11/2013 - 09/2011
2	Diethylstilbestrol (Stilbestrol)FDA Link 03/2013 - 04/2012
2	Estradiol Congeners (Synthetic Estrogens)IBA 03/2013 - 04/2012
2	Leptin ReceptorsIBA 10/2006 - 04/2006
1	Endocrine DisruptorsIBA 04/2022
1	Transfer RNA (tRNA)IBA 01/2021
1	AMP-Activated Protein KinasesIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Amino Acids FDA Link 01/2018
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2017
1	Tamoxifen FDA LinkGeneric 01/2017
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 01/2017
1	Galectin 3 (LGALS3)IBA 01/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	Corn Oil (Oil, Corn)IBA 01/2016
1	benz(a)anthracene (benzanthracene)IBA 06/2014
1	Oral ContraceptivesIBA 03/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2011
1	Phenobarbital (Luminal)FDA Link 09/2011
1	GenisteinIBA 09/2011
1	AmphiregulinIBA 09/2011
1	Messenger RNA (mRNA)IBA 09/2011
1	Caveolin 1IBA 06/2010
1	Dietary Fats (Dietary Fat)IBA 04/2009
1	Progesterone FDA LinkGeneric 04/2009
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 04/2009
1	Insulin-Like PeptidesIBA 10/2006
1	Mitogen-Activated Protein KinasesIBA 04/2006
1	AdiponectinIBA 04/2006
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2006
1	Insulin (Novolin)FDA Link 04/2006
1	Epoxide HydrolasesIBA 12/2002

Therapy/Procedure

2	Therapeutics 01/2017 - 03/2013
1	Diet Therapy (Therapy, Diet) 10/2010